Project Details
Abstract
The nanotechnology has been enormously applied to drug delivery systems. Nano-scale lipid
carriers consist of solid lipid nanoparticles(SLN), Nano-structured lipid carriers (NLC), and
nanoemulsion, microemulsion, which are suitable for the delivery of low-bioavailable and
hydrophobic drugs. Curcumin, a polyphenolic compound, has several activities such as
anti-oxidant, anti-aging, reducing cholesterol adsorption, alleviating gastric ulcer, and
inhibiting angiogenesis. Curcumin also reported to relieve rheumatalgia, muscle pains,
arthritis, and to reduce the occurrence of skin cancer, and skin inflammation. The application
of curcumin for the therapeutics of skin diseases is very potential by using the topic
transdermal route. In addition, the characteristics of lipophilic and low water solubility of
curcumin are very suitable for the lipid-based delivery system. The nano-scale size of
lipid-curcumin complex (nano-curcumin) can be retained on the stratum corneum and dermis
and can be slowly released by the depot effects. This project is aimed at increasing the
bioavailability of curcumin by optimizing the important compositions such as chemical
enhancers, surfactants, cosurfactants, and oils by using the statistical design method. The
optimization target is to find stable and uniform lipid-based carriers with controlled
transdermal release properties. In the first year, the physicochemical property of
nano-curcumin will be characterized and the cytotoxicity will be analyzed. In the second year,
the in vitro and in vivo transdermal delivery and toxicity of nano-curcumin will be
characterized and analyzed by using the murine models. In the third year, the in vivo anti-skin
cancer effects of nano-curcumin will be evaluated by using the murine models. The aims of
this three-year study include: 1. the nano-scale formulation development for nano-curcumin 2.
the physicochemical properties of nano-lipid carriers, 3. the in vitro release mathematical
models of different nano-curcumins, 4. mechanism and efficiency analysis of the delivery
systems by the transdermal route, 5. the topic and transdermal effects of curcumin in murine
skin cancer models.
Project IDs
Project ID:PB9907-12658
External Project ID:NSC99-2628-E182-002
External Project ID:NSC99-2628-E182-002
Status | Finished |
---|---|
Effective start/end date | 01/08/10 → 31/07/11 |
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.